Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Xtract One Technologies Inc. T.XTRA

Alternate Symbol(s):  XTRAF | T.XTRA.WT

Xtract One Technologies Inc. is a Canada-based technology-driven threat detection and security solution provider, leveraging artificial intelligence (AI) to provide secure patron access control experiences. The Company's segments include Platform and Xtract. The Platform segment develops and commercializes a platform of AI-powered threat detection technologies. The Xtract segment develops and commercializes advanced artificial intelligence solutions for customers. Its products include SafeGateway, SmartGateway and Xtract One View. Its Gateway product enables companies to covertly screen for weapons at points of entry without disrupting the flow of traffic. Its AI-based software allows venue and building operators to identify weapons and other threats inside and outside of facilities and receive intelligence for optimizing operations. Xtract One View, the Company's cloud-based platform, provides oversight of its customers entire fleet of Xtract One SmartGateways from one interface.


TSX:XTRA - Post by User

Comment by Nightstockeron Dec 02, 2021 5:15pm
189 Views
Post# 34192275

RE:RE:RE:RE:From NCS4

RE:RE:RE:RE:From NCS4

@Pliskin- I think since these were separate, independent trials, it's unlikely Evolv would be in a position to influence the outcome of Pat's performance and it's release to the public.

That said, they might be trying to delay the results of the Express operational exercise if it was a gong show. Ya never know. Total speculation on my part.

<< Previous
Bullboard Posts
Next >>